Semaglutide
-
healthSemaglutide Shows Promise in Reversing Osteoarthritis Damage
New research suggests semaglutide, known for diabetes and weight loss, may reverse joint tissue damage in osteoarthritis by reprogramming cell metabolism.
-
healthNew Pill Orforglipron Outperforms Ozempic in Key Diabetes and Weight Loss Trial
A groundbreaking Phase 3 trial reveals orforglipron, an oral GLP-1 drug, demonstrates superior efficacy in blood sugar control and weight reduction compared to oral semaglutide.
-
healthEli Lilly's Orforglipron Pill Shows Superior Weight Loss in Trials
New oral weight-loss drug orforglipron demonstrates significant efficacy in clinical trials, outperforming existing oral semaglutide treatments.
-
sportsWeight Loss Jabs Under Fire: Could They Be Banned from the Olympics?
World Anti-Doping Agency (WADA) is reviewing Semaglutide, the active ingredient in popular weight loss drugs, for potential bans in elite sports.
-
healthDiabetes Drug Semaglutide Linked to Vision Loss Risk
New research suggests semaglutide, a popular diabetes and weight loss drug, may increase the risk of optic neuropathy and vision loss. Experts urge careful patient counseling.